natgillin/translations-raw huggingface dataset:
These studies support the use of MabThera with any chemotherapy.
Te študije podpirajo uporabo zdravila MabThera s katerokoli kemoterapijo.
These studies will look at the medicine’s safety and effectiveness, and how it is used in real life.
V teh študijah bodo raziskovali varnost in učinkovitost zdravila ter njegovo dejansko uporabo.
These study data are insufficient to demonstrate efficacy and, therefore, Kineret is not recommended for pediatric use in Juvenile Rheumatoid Arthritis.
Podatki iz te študije ne zadoščajo za dokaz učinkovitosti in zato se zdravilo Kineret ne priporoča za pediatrično uporabo pri juvenilnem revmatoidnem artritisu.
These subjects had a Cmax concentration about 3-fold higher at approximately 7 hours with a terminal phase half-life of approximately 89 hours.
Ti preiskovanci so imeli po približno 7 urah okoli 3-krat večjo koncentracijo Cmax, razpolovna doba končne faze pa je znašala približno 89 ur.
These substances are ‘cytotoxic’.
Te učinkovine so „citotoksične“.
These substances decrease the action of GH and levels of IGF-I circulating in the blood.
Ta snov zmanjšuje delovanje rastnega hormona in raven IGF-I v obtoku.
These substances help to kill abnormal cells in the skin that can lead to keratosis.
Te snovi pomagajo uničiti nenormalne celice v koži, ki se lahko razvijejo v keratoze.
These substances should not be used in conjunction with stiripentol in the management of Dravet’s syndrome.
Teh snovi se pri obravnavi Dravetovega sindroma ne sme uporabiti pri sočasno s stiripentolom.
These substances should not be used in conjunction with stiripentol in the management of Dravet’s syndrome.
Teh snovi se pri obravnavi Dravetovega sindroma ne sme uporabiti sočasno s stiripentolom.
These substitutions were correlated with varying levels of reduced enfuvirtide susceptibility in HIV site- directed mutants.
Te substitucije so bile korelirane z različnimi stopnjami zmanjšane dovzetnosti za enfuvirtid v lokacijsko usmerjenih mutantah HIV.
These substitutions were observed only in the presence of LVDr substitutions (rtM204Vand rtL180M).
Te substitucije so opazili le ob prisotnosti substitucij LVDr (rtM204V in rtL180M).
These surveillance data actually suggest that varicella-vaccinated children may have a lower risk of herpes zoster.
Ti podatki stalnega spremljanja pravzaprav nakazujejo, da je pri otrocih, cepljenih proti noricam, tveganje za pojav pasavca lahko manjše.
These symptoms are either alleviated or their duration is reduced with Leganto treatment.
Ti simptomi se bodisi omilijo ali pa se njihovo trajanje skrajša ob zdravljenju z zdravilom Leganto.
These symptoms are either alleviated or their duration is reduced with Leganto treatment. the signs and symptoms of Parkinson’s disease in adults either alone or in combination with the medicine called levodopa.
Ti simptomi se bodisi omilijo ali pa se njihovo trajanje skrajša ob zdravljenju z zdravilom Leganto. znakov in simptomov Parkinsonove bolezni pri odraslih bodisi kot samostojno zdravljenje ali v kombinaciji z zdravilom imenovanim L-dopa
These symptoms are either alleviated or their duration is reduced with Neupro treatment.
Ti simptomi se bodisi omilijo ali pa se njihovo trajanje skrajša ob zdravljenju z zdravilom Neupro.
These symptoms are either alleviated or their duration is reduced with Neupro treatment. the signs and symptoms of Parkinson’s disease in adults either alone or in combination with the medicine called levodopa.
Ti simptomi se bodisi omilijo ali pa se njihovo trajanje skrajša ob zdravljenju z zdravilom Neupro. znakov in simptomov Parkinsonove bolezni pri odraslih bodisi kot samostojno zdravljenje ali v kombinaciji z zdravilom imenovanim L-dopa
These symptoms are probably caused by the body’s immune system becoming stronger, so that the body starts to fight these infections.
Ti simptomi so verjetno posledica okrepitve imunskega sistema in se organizem zopet prične boriti proti tem okužbam.
These symptoms are probably caused by the body’s immune system becoming stronger, so that the body starts to fight these infections.
Ti simptomi so verjetno posledica okrepitve imunskega sistema, s tem da se organizem zopet prične boriti proti tem okužbam.
These symptoms are probably caused by the body’s immune system becoming stronger, so that the body starts to fight these infections.
Ti simptomi so verjetno posledica okrepitve imunskega sistema, zaradi česar se organizem začne boriti proti tem okužbam.
These symptoms are probably caused by the body’s immune system becoming stronger, so that the body starts to fight these infections.
Ti simptomi so verjetno posledica okrepitve telesnega imunskega sistema, ko se telo lahko začne boriti s temi okužbami.
These symptoms are typically in association with the first dose, generally of short duration, mild or moderate in intensity, and usually resolve during continuing treatment, without requiring remedial measures (please see paragraph “Influenza like illness”).
Ti simptomi so značilno povezani s prvim odmerkom, ponavadi so kratkotrajni, blagi do zmerno močni in ponavadi izginejo z nadaljevanjem zdravljenja brez posegov v samo zdravljenje (prosimo, glejte odstavek Bolezen, podobna gripi).
These symptoms are usually mild, are more common at the start of the treatment and decrease with continued use.
Ti simptomi so običajno blagi in pogostejši na začetku zdravljenja, z nadaljno uporabo pa se zmanjšujejo.
These symptoms are usually of transitory nature.
Ponavadi so prehodni.
These symptoms are very common (they may affect more than 1 in 10 people):
Ti simptomi so zelo pogosti (pojavijo se lahko pri več kot 1 od 10 bolnikov):
These symptoms could be a sign of “diabetic ketoacidosis” – a problem you can get with diabetes because of increased levels of “ketone bodies” in your urine or blood, seen in tests.
Ti simptomi so lahko znak "diabetične ketoacidoze" – motnje, ki se lahko pojavi pri sladkorni bolezni zaradi zvišane ravni "ketonskih teles" v urinu ali krvi; pokaže se na laboratorijskih preiskavah.
These symptoms could be a sign of “diabetic ketoacidosis” – a problem you can get with diabetes because of increased levels of “ketone bodies” in your urine or blood, seen in tests.
Ti simptomi so lahko znak “diabetične ketoacidoze”, težave, ki se lahko pojavi pri sladkorni bolezni zaradi povišanih ravni “ketonskih teles” v urinu ali krvi, kar je razvidno iz laboratorijskih preiskav.
These symptoms could be a sign of “diabetic ketoacidosis” – a problem you can get with diabetes because of increased levels of “ketone bodies” in your urine or blood, seen in tests.
Ti simptomi so lahko znaki “diabetične ketoacidoze” – motnje, ki se lahko pojavi pri sladkorni bolezni zaradi povečane koncentracije “ketonskih teles” v urinu in krvi, kar pokažejo laboratorijske preiskave.
These symptoms could be due to an infection caused by low levels of white blood cells (called leucopenia or neutropenia).
To so lahko simptomi okužbe, do katere pride zaradi znižanega števila belih krvnih celic (kar imenujemo levkopenija ali nevtropenija).
These symptoms have been reported more frequently when shosaikoto, a Chinese herbal medicine, is administered concomitantly with interferon alpha (see section 4.4).
O teh simptomih so poročali pogosteje pri sočasni uporabi kitajskega zeliščnega pripravka shosaikoto z interferonom alfa (glejte poglavji 4.4).
These symptoms have been reported more frequently when shosaikoto, a Chinese herbal medicine, is administered concomitantly with interferon alpha (see section 4.4).
O teh simptomih so poročali pogosteje pri sočasni uporabi kitajskega zeliščnega pripravka shosaikoto z interferonom alfa (glejte točko poglavje 4.4).
These symptoms include itching and hives.
Med takšnimi simptomi sta srbenje in koprivke.
These symptoms include sneezing, runny or itchy nose, itchy palate, and itchy, red or watery eyes.
Med takšnimi simptomi so kihanje, srbenje nosu ali izcedek iz nosu, srbenje ustnega neba ter srbeče, pordele ali solzeče se oči.
These symptoms may be early signs of an allergic reaction.
Ti simptomi so lahko zgodnji znaki alergijske reakcije.
These symptoms may be reduced by taking paracetamol or non- steroidal anti-inflammatory medicines such as ibuprofen.
Te simptome je mogoče ublažiti z jemanjem paracetamola ali nesteroidnih protivnetnih zdravil, kot je na primer ibuprofen.
These symptoms may be reduced by taking paracetamol or non-steroidal anti- inflammatory medicines such as ibuprofen.
Te simptome je mogoče ublažiti z jemanjem paracetamola ali nesteroidnih protivnetnih zdravil, kot je ibuprofen.
These symptoms may be reduced by taking paracetamol or non-steroidal anti-inflammatory medicines such as ibuprofen.
Te simptome je mogoče ublažiti z jemanjem paracetamola ali nesteroidnih protivnetnih zdravil, kot je na primer ibuprofen.
These symptoms may happen when you start taking metformin and usually go away
Ti simptomi se lahko pojavijo na začetku jemanja metformina in običajno izginejo.
These symptoms may indicate that your body’s improved immune system is fighting infection.
Ti simptomi lahko nakazujejo, da se izboljšan imunski sistem vašega telesa bori proti okužbi.
These symptoms may indicate that your body’s improved immune system is fighting infection.
Ti simptomi lahko nakazujejo, da se izboljšani imunski sistem vašega telesa bojuje proti okužbi.
These symptoms may indicate that your child’s body’s improved immune system is fighting infection.
Ti simptomi lahko nakazujejo, da se izboljšani imunski sistem otrokovega telesa bojuje proti okužbi.
These symptoms may occur up to three days after treatment with zoledronic acid.
Ti simptomi se lahko pojavijo tudi do tri dni po zdravljenju z zoledronsko kislino,
These symptoms may resemble those observed with non- selective MAO inhibitors.
Ti simptomi so lahko podobni simptomom, ki jih je mogoče opaziti pri neselektivnih inhibitorjih MAO.
These symptoms often develop before the symptoms of a low sugar level in the brain.
Ti simptomi se pogosto razvijejo pred simptomi nizke koncentracije sladkorja v možganih.
These symptoms vary from patient to patient but usually involve problems such as difficulty with walking, vision and balance.
Ti simptomi se med bolniki razlikujejo, vendar običajno vključujejo težave s hojo, vidom in ravnotežjem.
These syringe sizes are appropriate for the possible range of starting doses, and quantities will be sufficient for one week of treatment.
Te velikosti brizg so primerne za različne začetne odmerke, količina pa bo zadoščala za en teden zdravljenja.
These tablets can be administered with or without food.
Te tablete se daje s hrano ali brez nje.
These tests will have confirmed that the HIV in your child’s blood is resistant to most other protease inhibitors.
Preizkus bo potrdil, da je HIV v otrokovi krvi odporen proti večini drugih zaviralcev proteaze.
These tests will monitor: the amount of blood cells (white blood cells, red blood cells and platelets) in your body to see how Tasigna is tolerated. pancreas and liver function in your body to see how Tasigna is tolerated. the electrolytes in your body (potassium, magnesium).
Preiskave bodo pokazale: število krvnih celic (levkocitov, eritrocitov in trombocitov) v telesu, da boste vedeli, kako prenašate zdravilo Tasigna. delovanje trebušne slinavke in jeter v vašem telesu, kar kaže, kako prenašate zdravilo Tasigna. vrednosti elektrolitov (kalija in magnezija) v telesu.
These three studies compared the effects of adding Orencia or placebo (a dummy treatment) with the other medicines that the patients were already taking for rheumatoid arthritis: these did not include a TNF blocker.
V teh treh študijah so primerjali učinke dodajanja zdravila Orencia ali placeba (zdravila brez zdravilne učinkovine) drugim zdravilom, ki so jih bolniki že jemali proti revmatoidnemu artritisu: med njimi ni bilo zaviralca TNF.
These three-week cycles should be repeated until the disease gets
Ti tritedenski cikli se ponavljajo, dokler se bolezen ne poslabša ali neželeni
These time points (treatment week 4 and treatment week 12) have been shown to be predictive for sustained response (Table 10).
. Za navedene časovne točke (4. teden zdravljenja in 12. teden zdravljenja) so pokazali, da napovedujejo trajni virološki odziv (Preglednica 10).
These tissues were fixed in formalin or Bouin’s fixative.
Tkiva so bila fiksirana s formalinom ali v Bouinsovem fiksativu.
These transitory false-positive results may due to IgM production in response to the vaccine.
Prehodno lažno pozitivni rezultati so lahko posledica nastajanja protiteles IgM kot odziv na cepivo.
These treatments may also weaken part of the immune system.
Vrsta ovojnine in vsebina
These treatments should be prescribed by doctors with experience in the care of patients with haemophilia A. Speak to your doctor if you would like further information on this.
Dodatno zdravljenje vam mora predpisati zdravnik, ki ima izkušnje z zdravljenjem bolnikov s hemofilijo A. Posvetujte se z zdravnikom, če v zvezi s tem potrebujete še kakršnekoli dodatne informacije.
These trials included rheumatoid arthritis patients with short term and long standing disease as well as psoriatic arthritis, ankylosing spondylitis and Crohn’s disease patients.
Ta preskušanja so vključila bolnike z revmatoidnim artritisom (tako tiste, ki so imeli bolezen kratek čas, kot tiste, ki so jo imeli že dolgo), psoriatičnim artritisom, ankilozirajočim spondilitisom in Crohnovo boleznijo.
These trials included rheumatoid arthritis patients with short term and long standing disease as well as psoriatic arthritis, ankylosing spondylitis and Crohn’s disease patients.
Ta preskušanja so vključila bolnike z revmatoidnim artritisom (tako tiste, ki so imeli bolezen kratek čas, kot tiste, ki so jo imeli že dolgo), psoriatičnim artritisom, ankilozirajočim sponditisom in Crohnovo boleznijo.
These trials included rheumatoid arthritis patients with short term and long standing disease as well as psoriatic arthritis, ankylosing spondylitis and Crohn’s disease patients.
Ta preskušanja so vključile bolnike z revmatoidnim artritisom (tako tiste, ki so imeli bolezen kratek čas, kot tiste, ki so jo imeli že dolgo), psoriatičnim artritisom, ankilozirajočim spondilitisom in Crohnovo boleznijo.
These trials included rheumatoid arthritis patients with short term and long standing disease, juvenile idiopathic arthritis (polyarticular juvenile idiopathic arthritis and enthesitis-related arthritis) as well as axial spondyloarthritis (ankylosing spondylitis and axial spondyloarthritis without radiographic evidence of AS), psoriatic arthritis, Crohn’s disease, ulcerative colitis, psoriasis, hidradenitis suppurativa and uveitis patients.
Ta preskušanja so vključila bolnike z revmatoidnim artritisom (tako tiste, ki so imeli bolezen kratek čas, kot tiste, ki so jo imeli že dolgo), juvenilnim idiopatskim artritisom (poliartikularnim juvenilnim idiopatskim artritisom in artritisom, povezanim z entezitisom), aksialnim spondiloartritisom (ankilozirajočim spondilitisom in aksialnim spondiloartritisom brez radiografskega dokaza za AS), psoriatičnim artritisom, Crohnovo boleznijo, ulceroznim kolitisom, psoriazo, hidradenitis suppurativa in uveitisom.
These trials included rheumatoid arthritis patients with short term and long standing disease, juvenile idiopathic arthritis (polyarticular juvenile idiopathic arthritis and enthesitis-related arthritis) as well as axial spondyloarthritis (ankylosing spondylitis and axial spondyloarthritis without radiographic evidence of AS), psoriatic arthritis, Crohn’s disease, ulcerative colitis, psoriasis, hidradenitis suppurativa and uveitis patients.
Ta preskušanja so vključila bolnike z revmatoidnim artritisom (tako tiste, ki so imeli bolezen kratek čas, kot tiste, ki so jo imeli že dolgo), juvenilnim idiopatskim artritisom (poliartikularnim juvenilnim idiopatskim artritisom in artritisom, povezanim z entezitisom), aksialnim spondiloartritisom (ankilozirajočim sponditisom in aksialnim spondiloartritisom brez radiografskega dokaza za AS), psoriatičnim artritisom, Crohnovo boleznijo, ulceroznim kolitisom, psoriazo, hidradenitis suppurativa in uveitisom.
These trials included rheumatoid arthritis patients with short term and long standing disease, juvenile idiopathic arthritis (polyarticular juvenile idiopathic arthritis and enthesitis-related arthritis) as well as axial spondyloarthritis (ankylosing spondylitis and axial spondyloarthritis without radiographic evidence of AS), psoriatic arthritis, Crohn’s disease, ulcerative colitis, psoriasis, hidradenitis suppurativa and uveitis patients.
Ta preskušanja so vključila bolnike z revmatoidnim artritisom (tako tiste, ki so imeli bolezen kratek čas, kot tiste, ki so jo imeli že dolgo), juvenilnim idiopatskim artritisom (poliartikularnim juvenilnim idiopatskim artritisom in artritisom, povezanim z entezitisom), aksialnim spondiloartritisom, (ankilozirajočim sponditisom in aksialnim spondiloartritisom brez radiografskega dokaza za AS), psoriatičnim artritisom, Crohnovo boleznijo, ulceroznim kolitisom, psoriazo, hidradenitis suppurativa in uveitisom.
These trials included rheumatoid arthritis patients with short term and long standing disease, juvenile idiopathic arthritis (polyarticular juvenile idiopathic arthritis and enthesitis-related arthritis) as well as axial spondyloarthritis (ankylosing spondylitis and axial spondyloarthritis without radiographic evidence of AS), psoriatic arthritis, Crohn’s disease, ulcerative colitis, psoriasis, hidradenitis suppurativa and uveitis patients.
Ta preskušanja so vključile bolnike z revmatoidnim artritisom (tako tiste, ki so imeli bolezen kratek čas, kot tiste, ki so jo imeli že dolgo), juvenilnim idiopatskim artritisom (poliartikularnim juvenilnim idiopatskim artritisom in artritisom, povezanim z entezitisom), aksialnim spondiloartritisom (ankilozirajočim spondilitisom in aksialnim spondiloartritisom brez radiografskega dokaza za AS), psoriatičnim artritisom, Crohnovo boleznijo, ulceroznim kolitisom, psoriazo, hidradenitis suppurativa in uveitisom.
These trials investigated Gazyvaro in combination with different chemotherapeutic agents (chlorambucil for CLL, bendamustine for iNHL) and as maintenance monotherapy (in iNHL only).
V teh preskušanjih so proučevali zdravilo Gazyvaro v kombinacijah z različnimi kemoterapevtiki (klorambucilom pri KLL, bendamustinom pri iNHL) in v vzdrževalnem zdravljenju v monoterapiji (samo pri iNHL).
These trials were identical in design and similar efficacy for INTELENCE was seen in each trial.
Ti dve preskušanji sta bili popolnoma enako načrtovani in v obeh so ugotovili podobno učinkovitost zdravila INTELENCE.
These trials, involving 1308 patients with a history of an average of 23 years of partial-onset seizures, were designed to evaluate the efficacy and safety of lacosamide when administered concomitantly with 1-3 antiepileptics in patients with uncontrolled partial-onset seizures with or without secondary generalisation.
Preskušanja, v katera je bilo vključenih 1308 bolnikov, ki so imeli v anamnezi parcialne napade v povprečju 23 let, so bila načrtovana za oceno učinkovitosti in varnosti lakozamida pri sočasnem jemanju z 1 do 3 antiepileptiki pri bolnikih z nenadzorovanimi parcialnimi napadi s sekundarno generalizacijo ali brez nje.
These tumours are considered as spontaneous renal cell carcinomas that are known to occur in aged nonhuman primates and are unlikely to be relevant to humans.
Za te tumorje velja, da so spontani karcinomi ledvičnih celic, ki se pojavljajo pri drugih ostarelih primatih in ne pri človeku, zato ni verjetno, da bi bili pomembni za ljudi.
These tumours can be related to prolonged dopamine D2 antagonism and hyperprolactinemia.
Ti tumorji so lahko povezani s podaljšanim antagonizmom dopamina D2 in hiperprolaktinemijo.
These two studies included a 10 week placebo and active (fluoxetine) controlled acute phase followed by six months period of active controlled extension treatment.
Ti dve študiji sta obsegali 10-tedensko akutno fazo s placebom in aktivno kontrolo (fluoksetinom), čemur je sledilo 6- mesečno podaljšano obdobje z aktivno kontrolo.
These types of capsules are known as modified- release capsules.
Tovrstne kapsule imenujemo kapsule s prirejenim sproščanjem.
These types of infection may range in severity from mild to life threatening.
Resnost takšnih okužb je lahko od blage do življenjsko nevarne.
These types of medicines will reduce your alertness levels making it difficult for you to drive and use machines.
Te vrste zdravil zmanjšajo pozornost, zato vas motijo pri vožnji in upravljanju strojev.
These undesirable effects generally occurred at the beginning of the treatment (few days to a few months) and were reversible after treatment discontinuation.
Ti neželeni učinki so se običajno pojavili na začetku zdravljenja (od nekaj dni do nekaj mesecev) in so bili reverzibilni ko se je zdravljenje prekinilo.
These units are exclusive to Apidra and are not the same as IU or the units used to express the potency of other insulin analogues (see section 5.1).
Te enote veljajo izključno za zdravilo Apidra in niso enake mednarodnim enotam (i.e.) ali enotam, ki se uporabljajo za izražanje jakosti drugih insulinskih analogov(glejte poglavje 5.1).
These usually go back to normal after you stop having this medicine.
Težave običajno izzvenijo, ko prenehate z zdravljenjem s tem zdravilom.
These values were calculated according to Medical Internal Radiation Dosimetry.
Vrednosti so bile izračunane v skladu z MIRD (Medical Internal Radiation Dosimetry).
These very common side effects may affect more than 1 in 10 people treated with Hycamtin:
Ti zelo pogosti neželeni učinki se lahko pojavijo pri več kot 1 od 10 bolnikov, ki se zdravijo z zdravilom Hycamtin:
These virologic failures appear to have resulted from reinfection based on analyses of baseline and virologic failure samples
Glede na analize izhodiščnih vzorcev in vzorcev ob virološkem neuspehu se zdi, da so bili ti virološki neuspehi posledica ponovne okužbe.
These visual impairments were transient and fully reversible, with the majority spontaneously resolving within 60 minutes and no clinically significant long-term visual effects were observed.
Okvare vida so bile prehodne in popolnoma reverzibilne; večina jih je spontano minila v 60 minutah in niso opazili nobenih klinično pomembnih dolgotrajnih učinkov na vid.
These visual impairmentswere transient and fully reversible, with the majority spontaneously resolving within 60 minutes and no clinically significant long-term visual effects were observed.
Okvare vida so bile prehodne in popolnoma reverzibilne; večina jih je spontano minila v 60 minutah in niso opazili nobenih klinično pomembnih dolgotrajnih učinkov na vid.
These were all CTCAE grade 1 and 2 with the exception of one CTCAE grade 3 raised alanine aminotransferase event.
Vsi navedeni neželeni učinki so bili stopnje 1 ali 2 po CTCAE razen enega primera zvišanja vrednosti alanin-aminotransferaze stopnje 3 po CTCAE.
These were comparable between groups, and the difference between groups did not exceed ≥2% incidence for the ZALTRAP/FOLFIRI regimen.
Med skupinama so bili primerljivi in razlika med skupinama ni presegla ≥ 2 % incidence s shemo ZALTRAP/FOLFIRI.
These were primarily asymptomatic HIV infected patients - Centre for Disease Control and Prevention (CDC) stage A. They were randomised to receive either abacavir 600 mg once daily or 300 mg twice daily, in combination with efavirenz and lamivudine given once daily.
V študijo so bili vključeni pretežno z virusom HIV okuženi asimptomatski bolniki – Center za nadzor in preprečevanje bolezni (CDC) stadij A. Randomizirani so bili tako, da so prejemali abakavir v odmerku 600 mg enkrat na dan ali v odmerku 300 mg dvakrat na dan v kombinaciji z efavirenzem in lamivudinom enkrat na dan.